Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AbbVie Inc Issues FY 2013 EPS Guidance In Line With Analysts' Estimates


Wednesday, 30 Jan 2013 08:49am EST 

AbbVie Inc announced that for fiscal 2013, it expects adjusted earnings per share (EPS) guidance of $3.03 to $3.13, or $2.66 to $2.76 on a Generally Accepted Accounting Principles (GAAP) basis. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.08 for fiscal 2013. 

Company Quote

68.06
0.28 +0.41%
25 Nov 2014